Conditioning Brain Responses to Improve Thigh Muscle Function After Anterior Cruciate Ligament Reconstruction
Launched by UNIVERSITY OF MICHIGAN · Jul 3, 2017
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to help people recover stronger thigh muscles after surgery for an anterior cruciate ligament (ACL) injury. The researchers want to see if a technique called operant conditioning, which is like mental coaching and encouragement, can improve muscle strength and activation. This could be important for people who have had an ACL reconstructive surgery and are struggling with muscle weakness afterward.
To participate in the study, you need to be between 18 and 45 years old and have recently had surgery for a complete ACL tear. Unfortunately, if you've had previous knee injuries or surgeries, certain health conditions, or specific medical devices, you might not be eligible. If you join the study, you can expect to take part in various tests and follow-up sessions that will help track your recovery progress. The trial is currently looking for participants, and every effort is made to ensure your safety and well-being throughout the process.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • aged 18-45 years
- • suffered an acute, complete ACL rupture
- • have undergone ACL reconstructive surgery
- • willingness to participate in testing and follow-up as outlined in the protocol
- Exclusion Criteria:
- • have suffered a previous ACL injury;
- • have undergone previous major surgery to either knee;
- • have a history of recent significant knee injury (other than ACL) or lower-extremity fracture;
- • have a history of uncontrolled diabetes or hypertension;
- • be pregnant or plan to become pregnant;
- • have metal implants in the head;
- • have electronic devices in their ear or heart (e.g., cochlear implants or cardiac pacemakers);
- • have unexplained recurrent headaches;
- • have a recent history of seizures;
- • be taking drugs that reduce seizure threshold;
- • have a history of repeated fainting spells;
About University Of Michigan
The University of Michigan, a leading academic institution renowned for its commitment to advancing healthcare and medical research, serves as a prominent clinical trial sponsor. With a robust infrastructure that supports innovative research initiatives, the university leverages its multidisciplinary expertise to conduct a wide array of clinical trials aimed at improving patient outcomes and advancing medical knowledge. Through its state-of-the-art facilities and collaborative environment, the University of Michigan fosters partnerships between researchers, clinicians, and industry leaders, ensuring the development of cutting-edge therapies and interventions that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ann Arbor, Michigan, United States
Patients applied
Trial Officials
Chandramouli Krishnan, PhD
Principal Investigator
Assistant Professor
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials